AceView: Gene:CHAC1, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
AA321496		.c-u	916 to 1244	1 to 330				330/330 (100 %)	1 diff (99.7 %id)
AA357110		.c-u	1047 to 1359	1 to 313				313/313 (100 %)	0 diff (100 %id)
AW964098		.c-u	1048 to 1498	1 to 451		AAA		451/451 (100 %)	0 diff (100 %id)
AW991379	breast_normal	.a	557 to 920	368 to 8			Submitted on the opposite strand	361/370 (97 %)	0 diff (100 %id)
AW991515	breast_normal	.a	555 to 934	390 to 10			Submitted on the opposite strand	381/390 (97 %)	0 diff (100 %id)
AY702027		.b	615 to 1204	1 to 590		tiling clone,		590/590 (100 %)	1 diff (99.9 %id)
BC001683	Muscle, rhabdomyosarcoma	.a	56 to 1552	10 to 1506		available from MGC, AAA		1497/1497 (100 %)	0 diff (100 %id)
BC001847	Muscle, rhabdomyosarcoma	.a	56 to 1552	1 to 1497		available from MGC, AAA		1497/1497 (100 %)	0 diff (100 %id)
BC019625	Liver, adenocarcinoma	.a	45 to 1552	1 to 1508		tiling clone, available from MGC, AAA		1508/1508 (100 %)	0 diff (100 %id)
BQ311858	breast_normal	.a	551 to 925	11 to 385				375/385 (97 %)	6 diff (98.5 %id)
BQ325498	colon_ins	.c-u	1146 to 1400	35 to 281				247/285 (86 %)	18 diff (93.7 %id)
CN256695	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.c-u	769 to 1345	1 to 577				577/577 (100 %)	5 diff (99.2 %id)
CN256696	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	68 to 603	1 to 536				536/536 (100 %)	0 diff (100 %id)
CN256697	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	65 to 683	1 to 618				618/618 (100 %)	2 diff (99.7 %id)
CN256698	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.c-u	1 to 759	8 to 766		tiling clone,		759/766 (99 %)	1 diff (99.9 %id)
CN256699	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.c-u	991 to 1495	9 to 514				506/514 (98 %)	1 diff (99.9 %id)
CR591065	B cells (Ramos cell line) Cot 25-normalized	.a	69 to 1518	1 to 1450				1450/1450 (100 %)	0 diff (100 %id)
CR592413	Neuroblastoma Cot 50-normalized	.a	58 to 1535	1 to 1478				1478/1478 (100 %)	0 diff (100 %id)
CR597001	HeLa cells Cot 25-normalized	.a	61 to 1524	1 to 1464				1464/1464 (100 %)	0 diff (100 %id)
CR598230	Neuroblastoma Cot 25-normalized	.a	56 to 1495	1 to 1440				1440/1440 (100 %)	0 diff (100 %id)
CR598799	T cells (Jurkat cell line) Cot10-normalized	.a	53 to 1529	1 to 1477				1477/1477 (100 %)	0 diff (100 %id)
CR601069	Neuroblastoma Cot 25-normalized	.a	56 to 1473	1 to 1418				1418/1418 (100 %)	0 diff (100 %id)
CR604510	Neuroblastoma Cot 25-normalized	.a	47 to 1525	1 to 1479				1479/1479 (100 %)	0 diff (100 %id)
CR608003	Neuroblastoma Cot 25-normalized	.a	61 to 1535	1 to 1475				1475/1475 (100 %)	0 diff (100 %id)
CR617904	B cells (Ramos cell line) Cot 25-normalized	.a	34 to 1539	1 to 1506				1506/1506 (100 %)	0 diff (100 %id)
CR620504	HeLa cells Cot 25-normalized	.a	45 to 1492	1 to 1448				1448/1448 (100 %)	0 diff (100 %id)
CR624884	HeLa cells Cot 25-normalized	.a	72 to 1550	1 to 1479				1479/1479 (100 %)	0 diff (100 %id)
BX366092	Neuroblastoma Cot 25-normalized	.a	49 to 895	1 to 843				843/843 (100 %)	8 diff (99.1 %id)
BX387146	Neuroblastoma Cot 25-normalized	.a	1399 to 2462	1058 to 1		tiling clone,		1058/1058 (100 %)	20 diff (98.2 %id)
BX387147	Neuroblastoma Cot 25-normalized	.a	49 to 1113	1 to 1054				1054/1054 (100 %)	15 diff (98.6 %id)
BX393730	Neuroblastoma Cot 25-normalized	.a	36 to 964	1 to 919				919/987 (93 %)	21 diff (97.9 %id)
AL523425	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	780 to 1504	751 to 34		fully sequenced,		718/751 (95 %)	20 diff (97.4 %id)
AL523426	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	61 to 810	1 to 741		fully sequenced,		741/741 (100 %)	2 diff (99.8 %id)
AL524641	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	854 to 1495	633 to 1		fully sequenced,		633/633 (100 %)	15 diff (97.7 %id)
AL524642	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	56 to 884	1 to 817		fully sequenced,		817/817 (100 %)	2 diff (99.8 %id)
AL524709	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	806 to 1473	662 to 1		fully sequenced,		662/662 (100 %)	21 diff (96.9 %id)
AL524710	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	56 to 836	1 to 762		fully sequenced,		762/762 (100 %)	0 diff (100 %id)
AL525941	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	47 to 854	1 to 806		fully sequenced,		806/806 (100 %)	1 diff (99.9 %id)
AL526154	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	824 to 1506	701 to 20		fully sequenced,		682/701 (97 %)	5 diff (99.3 %id)
BX354515	Neuroblastoma Cot 25-normalized	.a	535 to 1504	953 to 1		fully sequenced,		953/953 (100 %)	19 diff (98.1 %id)
BX354516	Neuroblastoma Cot 25-normalized	.a	59 to 565	1 to 510		fully sequenced,		510/510 (100 %)	25 diff (95.1 %id)
AL528560	brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized	.a	58 to 792	1 to 725		fully sequenced,		725/725 (100 %)	12 diff (98.4 %id)
AL563188	brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized	.a	762 to 1534	762 to 1		fully sequenced,		762/762 (100 %)	30 diff (96.1 %id)
AL529164	brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized	.a	49 to 784	1 to 736				736/736 (100 %)	0 diff (100 %id)
AL530279	brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized	.a	1414 to 2464	1050 to 6		tiling clone,		1045/1069 (97 %)	0 diff (100 %id)
AL530280	brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized	.a	46 to 1136	1 to 1077				1077/1080 (99 %)	16 diff (98.6 %id)
BX421579	T cells (Jurkat cell line)	.a	47 to 1151	1 to 1088				1088/1094 (99 %)	29 diff (97.4 %id)
BX340878		.a	52 to 957	1 to 907				907/907 (100 %)	52 diff (94.3 %id)
AL559612	T cells from T cell leukemia	.a	59 to 981	1 to 925				925/982 (94 %)	31 diff (96.9 %id)
AL581190	T cells from T cell leukemia	.a	1125 to 1517	395 to 1				395/643 (61 %)	9 diff (98.7 %id)
BX341273		.a	744 to 1529	787 to 1		fully sequenced,		787/787 (100 %)	14 diff (98.3 %id)
BX341274		.a	53 to 774	1 to 722		fully sequenced,		722/722 (100 %)	0 diff (100 %id)
BX341841		.a	1258 to 1504	265 to 20		fully sequenced,		677/696 (97 %)	14 diff (98.0 %id)
BX341842		.a	61 to 820	1 to 747		fully sequenced,		747/747 (100 %)	4 diff (99.5 %id)
AL555217	placenta	.a	45 to 808	1 to 763		fully sequenced,		763/763 (100 %)	0 diff (100 %id)
AL577767	placenta	.a	778 to 1492	713 to 1		fully sequenced,		713/713 (100 %)	6 diff (99.2 %id)
BX342065		.a	72 to 988	1 to 906		fully sequenced,		906/906 (100 %)	4 diff (99.6 %id)
BX393254		.a	958 to 1549	602 to 1		fully sequenced,		602/602 (100 %)	29 diff (95.2 %id)
BX363571		.a	677 to 1539	851 to 1		fully sequenced,		851/851 (100 %)	6 diff (99.3 %id)
BX384820		.a	60 to 707	26 to 667		fully sequenced,		642/667 (96 %)	7 diff (99.0 %id)
BX342645		.a	45 to 984	1 to 935				935/935 (100 %)	18 diff (98.1 %id)
AL560697	B cells from Burkitt lymphoma	.a	69 to 915	1 to 842		fully sequenced,		842/842 (100 %)	3 diff (99.7 %id)
AL582108	B cells from Burkitt lymphoma	.a	885 to 1518	616 to 1		fully sequenced,		616/616 (100 %)	12 diff (98.1 %id)
CV026090	mixed	.a	147 to 709	1 to 563				563/563 (100 %)	0 diff (100 %id)
EH351731		.c-u	896 to 955	1 to 60				60/60 (100 %)	0 diff (100 %id)
ES309947	scalp interfollicular dermis, skin	.a	45 to 529	1 to 485				485/495 (97 %)	1 diff (99.8 %id)
ES314464	occipital scalp hair, skin	.b	547 to 728	1 to 180				180/180 (100 %)	2 diff (98.9 %id)
ES315483	occipital scalp hair, skin	.c-u	1350 to 1505	177 to 23		AAA	Submitted on the opposite strand	155/155 (100 %)	1 diff (99.4 %id)
DR978330	brain	.c-u	856 to 972	116 to 1				116/140 (82 %)	2 diff (98.6 %id)
R55677	whole brain	.b	477 to 853	1 to 376				376/487 (77 %)	9 diff (98.2 %id)
W19325	senescent fibroblast	.a	1253 to 1563	325 to 1		fully sequenced,		325/325 (100 %)	11 diff (96.7 %id)
W25488	senescent fibroblast	.a	896 to 1283	1 to 393		fully sequenced,		393/393 (100 %)	17 diff (95.7 %id)
AA535031	colon	.c-u	1053 to 1501	449 to 1				449/449 (100 %)	7 diff (98.5 %id)
AA894653	Kidney	.c-u	1332 to 1498	166 to 1				166/166 (100 %)	1 diff (99.4 %id)
AI279622	carcinoid, lung	.c-u	1223 to 1498	288 to 13		AAA		276/276 (100 %)	1 diff (99.7 %id)
AI433067	adenocarcinoma, Pancreas	.c-u	1190 to 1498	309 to 1				309/309 (100 %)	0 diff (100 %id)
AI459053	carcinoid, lung	.c-u	1116 to 1498	396 to 14		AAA		383/383 (100 %)	1 diff (99.8 %id)
AI638823	pooled germ cell tumors	.c-u	1230 to 1499	277 to 8				270/277 (97 %)	0 diff (100 %id)
AI628434	Kidney	.c-u	1051 to 1498	447 to 1				447/447 (100 %)	2 diff (99.6 %id)
AI671554	pooled germ cell tumors	.c-u	1230 to 1499	277 to 8				270/277 (97 %)	0 diff (100 %id)
AI655052	pooled germ cell tumors	.c-u	1230 to 1499	277 to 8				270/277 (97 %)	0 diff (100 %id)
AI911127	pooled	.c-u	1073 to 1498	445 to 20		AAA		426/426 (100 %)	2 diff (99.6 %id)
AI700697	carcinoid, lung	.c-u	1126 to 1498	386 to 14		AAA		373/373 (100 %)	5 diff (98.7 %id)
AW083365	colon, moderately differentiated adenocarcinoma	.c-u	1090 to 1498	411 to 1				411/411 (100 %)	3 diff (99.3 %id)
AW275368	Kidney	.c-u	1086 to 1498	413 to 1				413/413 (100 %)	0 diff (100 %id)
AW411028	muscle, rhabdomyosarcoma	.a	56 to 618	10 to 572				563/572 (98 %)	6 diff (99.0 %id)
AW411029	muscle, rhabdomyosarcoma	.a	1097 to 1552	487 to 32		AAA		456/456 (100 %)	0 diff (100 %id)
BE669506	carcinoid, lung	.c-u	1076 to 1498	440 to 18		AAA		423/423 (100 %)	5 diff (98.9 %id)
BF001389	colon, colon tumor, RER+	.c-u	1072 to 1499	431 to 4				428/431 (99 %)	0 diff (100 %id)
BE544298	cervical carcinoma cell line, cervix	.c-u	734 to 1446	1 to 706				706/821 (85 %)	11 diff (98.7 %id)
BE544293	cervical carcinoma cell line, cervix	.c-u	734 to 1498	1 to 753				753/785 (95 %)	33 diff (95.8 %id)
BF307602	muscle, rhabdomyosarcoma	.a	55 to 784	1 to 713				713/917 (77 %)	22 diff (97.7 %id)
BF306790	muscle, rhabdomyosarcoma	.c-u	679 to 1412	1 to 714				714/824 (86 %)	18 diff (97.9 %id)
BF796767	lymph, lymphoma, cell line	.a	38 to 818	1 to 766				766/960 (79 %)	29 diff (97.0 %id)
BG177191	lymph, lymphoma, cell line	.d	1 to 765	1 to 766	H5Q R6Q T7N L8P V9G ...	tiling clone,		766/847 (90 %)	29 diff (96.6 %id)
BG252187	adenocarcinoma, cell line, Liver	.a	46 to 771	1 to 720				720/736 (97 %)	13 diff (98.3 %id)
BG395253	eye, retinoblastoma	.c-u	535 to 999	1 to 465				465/465 (100 %)	1 diff (99.8 %id)
BG489543	large cell carcinoma, lung	.a	211 to 920	1 to 709				709/709 (100 %)	12 diff (98.4 %id)
BI193464	epithelioid carcinoma cell line, Pancreas	.a	71 to 688	1 to 626				626/790 (79 %)	31 diff (96.1 %id)
BI826016	brain, medulla	.a	21 to 790	1 to 770				770/770 (100 %)	0 diff (100 %id)
BI819368	pooled brain, lung, testis	.a	45 to 819	1 to 776				776/776 (100 %)	9 diff (98.9 %id)
BI761404	pooled colon, kidney, stomach	.a	45 to 712	1 to 678				678/678 (100 %)	21 diff (97.0 %id)
BI755067	brain	.a	46 to 818	1 to 770				770/770 (100 %)	8 diff (99.0 %id)
BI756086	brain	.a	208 to 1035	1 to 828				828/828 (100 %)	1 diff (99.9 %id)
BI756525	brain	.a	25 to 823	1 to 806				806/810 (99 %)	16 diff (98.1 %id)
BI753500	brain	.a	46 to 552	1 to 507				507/507 (100 %)	1 diff (99.9 %id)
BM043235	carcinoma, cell line, Prostate	.a	564 to 1119	10 to 568				559/570 (98 %)	5 diff (99.2 %id)
BM043783	carcinoma, cell line, Prostate	.a	564 to 942	11 to 392				382/583 (65 %)	7 diff (98.8 %id)
BM043806	carcinoma, cell line, Prostate	.a	564 to 967	11 to 415				405/546 (74 %)	4 diff (99.3 %id)
BM043884	carcinoma, cell line, Prostate	.a	564 to 1159	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM048538	carcinoma, cell line, Prostate	.a	564 to 1161	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM046215	carcinoma, cell line, Prostate	.a	564 to 1114	11 to 561				551/561 (98 %)	6 diff (99.0 %id)
BM012901	brain, neuroblastoma, cell line	.a	46 to 817	1 to 770				770/770 (100 %)	14 diff (98.2 %id)
BM456254	lymph, lymphoma, cell line	.a	69 to 793	1 to 740				740/823 (89 %)	25 diff (97.0 %id)
BM454177	lymph, lymphoma, cell line	.a	73 to 683	1 to 613				613/1099 (55 %)	9 diff (99.2 %id)
BM556362	duodenal adenocarcinoma, cell line, small intestine	.a	68 to 920	13 to 885				873/996 (87 %)	35 diff (96.5 %id)
BM925846	brain	.a	79 to 1023	16 to 972				957/1003 (95 %)	40 diff (96.1 %id)
BQ049395	lymph, lymphoma, cell line	.c-u	987 to 1501	1 to 515		AAA		515/515 (100 %)	0 diff (100 %id)
BM999571	Fibrosarcoma	.c-u	768 to 1501	755 to 19		AAA		737/737 (100 %)	4 diff (99.5 %id)
BQ421076	epithelioid carcinoma, Pancreas	.a	457 to 1039	1 to 582				582/592 (98 %)	5 diff (99.2 %id)
BQ221809	large cell carcinoma, lung	.a	62 to 947	1 to 888				888/888 (100 %)	8 diff (99.1 %id)
BQ229688	large cell carcinoma, lung	.a	70 to 836	1 to 768				768/842 (91 %)	2 diff (99.8 %id)
BQ215990	large cell carcinoma, lung	.b	1 to 787	1 to 795		tiling clone,		795/887 (89 %)	23 diff (97.5 %id)
BU838199	melanotic melanoma, cell line, skin	.b	188 to 890	1 to 703		tiling clone,		703/882 (79 %)	3 diff (99.7 %id)
BQ900544	brain, neuroblastoma, cell line	.a	1 to 910	1 to 920	T263X E264R Q265A L269P V270G	tiling clone,		920/950 (96 %)	16 diff (98.4 %id)
BU502776	carcinoma, cell line, Prostate	.c-u	505 to 1188	1 to 689	exact			689/947 (72 %)	12 diff (98.8 %id)
BU552621	carcinoma, cell line, Prostate	.c-u	505 to 1360	1 to 861	exact	tiling clone,		861/904 (95 %)	16 diff (98.3 %id)
CX762132	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	60 to 724	35 to 688			Submitted on the opposite strand	654/784 (83 %)	32 diff (96.0 %id)
TI_57215982		.a	46 to 818	28 to 797				770/797 (96 %)	13 diff (98.4 %id)
TI_57216375		.a	208 to 1035	35 to 862				828/862 (96 %)	7 diff (99.2 %id)
TI_57216888		.a	25 to 823	31 to 836				806/840 (95 %)	19 diff (97.8 %id)
TI_57218271		.a	46 to 552	32 to 538				507/538 (94 %)	6 diff (98.9 %id)
TI_57197578		.a	45 to 819	32 to 807				776/807 (96 %)	11 diff (98.7 %id)
TI_57147314		.a	45 to 712	71 to 748				678/748 (90 %)	22 diff (97.1 %id)
TI_57173708		.a	21 to 790	29 to 798				770/798 (96 %)	6 diff (99.3 %id)
TI_59382133		.a	47 to 817	121 to 889				769/769 (100 %)	13 diff (98.4 %id)
CB118517	Liver	.a	99 to 486	41 to 428				388/428 (90 %)	5 diff (98.9 %id)
CB123885	Liver	.a	99 to 443	41 to 385				345/385 (89 %)	5 diff (98.8 %id)
NM_024111.3		.a	1 to 1560	1 to 1560	exact	RefSeq, AAA		1560/1560 (100 %)	0 diff (100 %id)
NM_001142776.1		.b	477 to 1901	1 to 1425	exact	RefSeq, AAA		1425/1425 (100 %)	0 diff (100 %id)
BM743219	stomach	.c-u	1067 to 1402	1 to 337				337/337 (100 %)	2 diff (99.5 %id)
BM741202	Ascites, stomach	.c-u	863 to 1501	1 to 639				639/639 (100 %)	2 diff (99.7 %id)
BM757102	Ascites, stomach	.c-u	863 to 1221	1 to 359				359/359 (100 %)	1 diff (99.8 %id)
BM757109	Ascites, stomach	.a	300 to 633	1 to 334				334/334 (100 %)	2 diff (99.5 %id)
BM784841	Ascites, stomach	.c-u	621 to 979	1 to 359				359/359 (100 %)	2 diff (99.5 %id)
BM766562	Ascites, stomach	.c-u	1171 to 1498	1 to 328				328/328 (100 %)	2 diff (99.4 %id)
BM770332	Ascites, stomach	.c-u	621 to 1094	1 to 475				475/475 (100 %)	3 diff (99.4 %id)
BM768609	stomach	.c-u	1114 to 1503	1 to 390		tiling clone,		390/390 (100 %)	0 diff (100 %id)
BM843362	stomach	.a	34 to 613	1 to 581				581/581 (100 %)	3 diff (99.5 %id)
BM850339	stomach	.a	1168 to 1558	1 to 391				391/398 (98 %)	1 diff (99.8 %id)
BM856289	stomach	.c-u	1146 to 1277	1 to 132				132/132 (100 %)	1 diff (99.3 %id)
BQ084298	stomach	.b	510 to 810	1 to 301				301/301 (100 %)	1 diff (99.7 %id)
DN994261	brain, whole brain	.a	54 to 633	9 to 588				580/588 (98 %)	6 diff (99.0 %id)
CA503402	Human Lung Epithelial cells, lung	.c-u	886 to 1498	632 to 19		AAA		614/614 (100 %)	1 diff (99.9 %id)
BM702585	eye, human retina	.c-u	1203 to 1506	1 to 304		tiling clone, AAA		304/304 (100 %)	0 diff (100 %id)
BQ447223	Knee, Osteoarthritic Cartilage	.c-u	1039 to 1498	479 to 19		AAA		461/461 (100 %)	2 diff (99.6 %id)
CB529304	Aveolar Macrophage, lung	.c-u	782 to 1498	734 to 19		AAA		716/716 (100 %)	1 diff (99.9 %id)
BX394112	Neuroblastoma Cot 25-normalized	.a	564 to 942	11 to 392			Suspected internal deletion, this clone was ignored	382/583 (65 %)	7 diff (98.8 %id)
BE677815	pooled	.a	564 to 942	11 to 392			Suspected internal deletion, this clone was ignored	382/583 (65 %)	7 diff (98.8 %id)
BM043806	carcinoma, cell line, Prostate	.a	564 to 967	11 to 415				405/546 (74 %)	4 diff (99.3 %id)
BM043806	carcinoma, cell line, Prostate	.a	564 to 967	11 to 415				405/546 (74 %)	4 diff (99.3 %id)
BM043884	carcinoma, cell line, Prostate	.a	564 to 1159	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM043884	carcinoma, cell line, Prostate	.a	564 to 1159	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM048538	carcinoma, cell line, Prostate	.a	564 to 1161	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM048538	carcinoma, cell line, Prostate	.a	564 to 1161	11 to 605				595/605 (98 %)	6 diff (99.1 %id)
BM046215	carcinoma, cell line, Prostate	.a	564 to 1114	11 to 561				551/561 (98 %)	6 diff (99.0 %id)
BM046215	carcinoma, cell line, Prostate	.a	564 to 1114	11 to 561				551/561 (98 %)	6 diff (99.0 %id)
BM012901	brain, neuroblastoma, cell line	.a	46 to 817	1 to 770				770/770 (100 %)	14 diff (98.2 %id)
BM012901	brain, neuroblastoma, cell line	.a	46 to 817	1 to 770				770/770 (100 %)	14 diff (98.2 %id)
BM456254	lymph, lymphoma, cell line	.a	69 to 793	1 to 740				740/823 (89 %)	25 diff (97.0 %id)
BM456254	lymph, lymphoma, cell line	.a	69 to 793	1 to 740				740/823 (89 %)	25 diff (97.0 %id)
BM454177	lymph, lymphoma, cell line	.a	73 to 683	1 to 613				613/1099 (55 %)	9 diff (99.2 %id)
BM454177	lymph, lymphoma, cell line	.a	73 to 683	1 to 613				613/1099 (55 %)	9 diff (99.2 %id)
BM556362	duodenal adenocarcinoma, cell line, small intestine	.a	68 to 920	13 to 885				873/996 (87 %)	35 diff (96.5 %id)
BM556362	duodenal adenocarcinoma, cell line, small intestine	.a	68 to 920	13 to 885				873/996 (87 %)	35 diff (96.5 %id)
BM925846	brain	.a	79 to 1023	16 to 972				957/1003 (95 %)	40 diff (96.1 %id)
BQ049395	lymph, lymphoma, cell line	.c-u	987 to 1501	1 to 515		AAA		515/515 (100 %)	0 diff (100 %id)
BQ049395	lymph, lymphoma, cell line	.c-u	987 to 1501	1 to 515		AAA		515/515 (100 %)	0 diff (100 %id)
BM999571	Fibrosarcoma	.c-u	768 to 1501	755 to 19		AAA		737/737 (100 %)	4 diff (99.5 %id)
BQ421076	epithelioid carcinoma, Pancreas	.a	457 to 1039	1 to 582				582/592 (98 %)	5 diff (99.2 %id)
BQ421076	epithelioid carcinoma, Pancreas	.a	457 to 1039	1 to 582				582/592 (98 %)	5 diff (99.2 %id)
BQ221809	large cell carcinoma, lung	.a	62 to 947	1 to 888				888/888 (100 %)	8 diff (99.1 %id)
BQ221809	large cell carcinoma, lung	.a	62 to 947	1 to 888				888/888 (100 %)	8 diff (99.1 %id)
BQ229688	large cell carcinoma, lung	.a	70 to 836	1 to 768				768/842 (91 %)	2 diff (99.8 %id)
BQ229688	large cell carcinoma, lung	.a	70 to 836	1 to 768				768/842 (91 %)	2 diff (99.8 %id)
BQ215990	large cell carcinoma, lung	.b	1 to 787	1 to 795		tiling clone,		795/887 (89 %)	23 diff (97.5 %id)
BQ215990	large cell carcinoma, lung	.b	1 to 787	1 to 795		tiling clone,		795/887 (89 %)	23 diff (97.5 %id)
BU838199	melanotic melanoma, cell line, skin	.b	188 to 890	1 to 703		tiling clone,		703/882 (79 %)	3 diff (99.7 %id)
BU838199	melanotic melanoma, cell line, skin	.b	188 to 890	1 to 703		tiling clone,		703/882 (79 %)	3 diff (99.7 %id)
BQ900544	brain, neuroblastoma, cell line	.a	1 to 910	1 to 920	T263X E264R Q265A L269P V270G	tiling clone,		920/950 (96 %)	16 diff (98.4 %id)
BQ900544	brain, neuroblastoma, cell line	.a	1 to 910	1 to 920	T263X E264R Q265A L269P V270G	tiling clone,		920/950 (96 %)	16 diff (98.4 %id)
BU502776	carcinoma, cell line, Prostate	.c-u	505 to 1188	1 to 689	exact			689/947 (72 %)	12 diff (98.8 %id)
BU502776	carcinoma, cell line, Prostate	.c-u	505 to 1188	1 to 689	exact			689/947 (72 %)	12 diff (98.8 %id)
BU552621	carcinoma, cell line, Prostate	.c-u	505 to 1360	1 to 861	exact	tiling clone,		861/904 (95 %)	16 diff (98.3 %id)
BU552621	carcinoma, cell line, Prostate	.c-u	505 to 1360	1 to 861	exact	tiling clone,		861/904 (95 %)	16 diff (98.3 %id)
CX762132	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	60 to 724	35 to 688			Submitted on the opposite strand	654/784 (83 %)	32 diff (96.0 %id)
CX762132	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	60 to 724	35 to 688			Submitted on the opposite strand	654/784 (83 %)	32 diff (96.0 %id)
TI_57215982		.a	46 to 818	28 to 797				770/797 (96 %)	13 diff (98.4 %id)
TI_57216375		.a	208 to 1035	35 to 862				828/862 (96 %)	7 diff (99.2 %id)
TI_57216888		.a	25 to 823	31 to 836				806/840 (95 %)	19 diff (97.8 %id)
TI_57218271		.a	46 to 552	32 to 538				507/538 (94 %)	6 diff (98.9 %id)
TI_57197578		.a	45 to 819	32 to 807				776/807 (96 %)	11 diff (98.7 %id)
TI_57147314		.a	45 to 712	71 to 748				678/748 (90 %)	22 diff (97.1 %id)
TI_57173708		.a	21 to 790	29 to 798				770/798 (96 %)	6 diff (99.3 %id)
TI_59382133		.a	47 to 817	121 to 889				769/769 (100 %)	13 diff (98.4 %id)
CB118517	Liver	.a	99 to 486	41 to 428				388/428 (90 %)	5 diff (98.9 %id)
CB123885	Liver	.a	99 to 443	41 to 385				345/385 (89 %)	5 diff (98.8 %id)
NM_024111.3		.a	1 to 1560	1 to 1560	exact	RefSeq, AAA		1560/1560 (100 %)	0 diff (100 %id)
NM_001142776.1		.b	477 to 1901	1 to 1425	exact	RefSeq, AAA		1425/1425 (100 %)	0 diff (100 %id)
BM743219	stomach	.c-u	1067 to 1402	1 to 337				337/337 (100 %)	2 diff (99.5 %id)
BM741202	Ascites, stomach	.c-u	863 to 1501	1 to 639				639/639 (100 %)	2 diff (99.7 %id)
BM741202	Ascites, stomach	.c-u	863 to 1501	1 to 639				639/639 (100 %)	2 diff (99.7 %id)
BM757102	Ascites, stomach	.c-u	863 to 1221	1 to 359				359/359 (100 %)	1 diff (99.8 %id)
BM757102	Ascites, stomach	.c-u	863 to 1221	1 to 359				359/359 (100 %)	1 diff (99.8 %id)
BM757109	Ascites, stomach	.a	300 to 633	1 to 334				334/334 (100 %)	2 diff (99.5 %id)
BM757109	Ascites, stomach	.a	300 to 633	1 to 334				334/334 (100 %)	2 diff (99.5 %id)
BM784841	Ascites, stomach	.c-u	621 to 979	1 to 359				359/359 (100 %)	2 diff (99.5 %id)
BM784841	Ascites, stomach	.c-u	621 to 979	1 to 359				359/359 (100 %)	2 diff (99.5 %id)
BM766562	Ascites, stomach	.c-u	1171 to 1498	1 to 328				328/328 (100 %)	2 diff (99.4 %id)
BM766562	Ascites, stomach	.c-u	1171 to 1498	1 to 328				328/328 (100 %)	2 diff (99.4 %id)
BM770332	Ascites, stomach	.c-u	621 to 1094	1 to 475				475/475 (100 %)	3 diff (99.4 %id)
BM770332	Ascites, stomach	.c-u	621 to 1094	1 to 475				475/475 (100 %)	3 diff (99.4 %id)
BM768609	stomach	.c-u	1114 to 1503	1 to 390		tiling clone,		390/390 (100 %)	0 diff (100 %id)
BM843362	stomach	.a	34 to 613	1 to 581				581/581 (100 %)	3 diff (99.5 %id)
BM850339	stomach	.a	1168 to 1558	1 to 391				391/398 (98 %)	1 diff (99.8 %id)
BM856289	stomach	.c-u	1146 to 1277	1 to 132				132/132 (100 %)	1 diff (99.3 %id)
BQ084298	stomach	.b	510 to 810	1 to 301				301/301 (100 %)	1 diff (99.7 %id)
DN994261	brain, whole brain	.a	54 to 633	9 to 588				580/588 (98 %)	6 diff (99.0 %id)
DN994261	brain, whole brain	.a	54 to 633	9 to 588				580/588 (98 %)	6 diff (99.0 %id)
CA503402	Human Lung Epithelial cells, lung	.c-u	886 to 1498	632 to 19		AAA		614/614 (100 %)	1 diff (99.9 %id)
CA503402	Human Lung Epithelial cells, lung	.c-u	886 to 1498	632 to 19		AAA		614/614 (100 %)	1 diff (99.9 %id)
BM702585	eye, human retina	.c-u	1203 to 1506	1 to 304		tiling clone, AAA		304/304 (100 %)	0 diff (100 %id)
BM702585	eye, human retina	.c-u	1203 to 1506	1 to 304		tiling clone, AAA		304/304 (100 %)	0 diff (100 %id)
BQ447223	Knee, Osteoarthritic Cartilage	.c-u	1039 to 1498	479 to 19		AAA		461/461 (100 %)	2 diff (99.6 %id)
BQ447223	Knee, Osteoarthritic Cartilage	.c-u	1039 to 1498	479 to 19		AAA		461/461 (100 %)	2 diff (99.6 %id)
CB529304	Aveolar Macrophage, lung	.c-u	782 to 1498	734 to 19		AAA		716/716 (100 %)	1 diff (99.9 %id)
CB529304	Aveolar Macrophage, lung	.c-u	782 to 1498	734 to 19		AAA		716/716 (100 %)	1 diff (99.9 %id)